Literature DB >> 9780208

Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells.

N H Senden1, T M Jeunhomme, J W Heemskerk, R Wagenvoord, C van't Veer, H C Hemker, W A Buurman.   

Abstract

Proinflammatory effects induced by the serine protease factor Xa were investigated in HUVEC. Exposure of cells to factor Xa (5-80 nM) concentration dependently stimulated the production of IL-6, IL-8, and monocyte chemotactic protein-1 (MCP-1) and the expression of E-selectin, ICAM-1, and VCAM-1, which was accompanied by polymorphonuclear leukocyte adhesion. The effects of factor Xa were blocked by antithrombin III, but not by the thrombin-specific inhibitor hirudin, suggesting that factor Xa elicits these responses directly and not via thrombin. IL-1alpha and TNF-alpha were not implicated, since neither the IL-1 receptor antagonist nor a TNF-neutralizing Ab could suppress the factor Xa responses. Active site-inhibited factor Xa and factor Xa depleted from gamma-carboxyglutamic acid residues were completely inactive. The effector cell protease receptor-1 (EPR-1) seems not to be involved since anti-EPR-1 Abs failed to inhibit cytokine production. Moreover, neither the factor X peptide Leu83-Leu88, representing the inter-epidermal growth factor sequence in factor Xa that mediates ligand binding to EPR-1, nor the peptide AG1, corresponding to the EPR-1 sequence Ser123-Pro137 implicated in factor Xa binding, inhibited the factor Xa-induced cytokine production. In conclusion, these findings indicate that factor Xa evokes a proinflammatory response in endothelial cells, which requires both its catalytic and gamma-carboxyglutamic acid-containing domain. The receptor system involved in these responses induced by factor Xa remains to be established.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780208

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.

Authors:  Rong Jiang; Ning-Ping Wang; Kenichi A Tanaka; Jerrold H Levy; Robert A Guyton; Zhi-Qing Zhao; Jakob Vinten-Johansen
Journal:  J Surg Res       Date:  2010-02-23       Impact factor: 2.192

2.  Roles of protease-activated receptors in a mouse model of endotoxemia.

Authors:  Eric Camerer; Ivo Cornelissen; Hiroshi Kataoka; Daniel N Duong; Yao-Wu Zheng; Shaun R Coughlin
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

3.  Inhibition of calcium-independent phospholipase A2 prevents inflammatory mediator production in pulmonary microvascular endothelium.

Authors:  Prerna Rastogi; Jane McHowat
Journal:  Respir Physiol Neurobiol       Date:  2008-11-18       Impact factor: 1.931

Review 4.  Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

Authors:  Michal Heger; Rowan F van Golen; Mans Broekgaarden; Renate R van den Bos; H A Martino Neumann; Thomas M van Gulik; Martin J C van Gemert
Journal:  Lasers Med Sci       Date:  2014-03       Impact factor: 3.161

Review 5.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 6.  Protease-activated receptor signalling by coagulation proteases in endothelial cells.

Authors:  Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2014-07-03       Impact factor: 5.249

7.  Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.

Authors:  E Camerer; W Huang; S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

8.  Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium.

Authors:  Ezequiel Álvarez; Beatriz Paradela-Dobarro; Sergio Raposeiras-Roubín; José Ramón González-Juanatey
Journal:  Br J Clin Pharmacol       Date:  2017-10-25       Impact factor: 4.335

9.  Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects.

Authors:  Evert de Jonge; Philip W Friederich; George P Vlasuk; William E Rote; Margaretha B Vroom; Marcel Levi; Tom van der Poll
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

10.  Effects of botropase on clotting factors in healthy human volunteers.

Authors:  Ashok K Shenoy; K V Ramesh; Mukta N Chowta; Prabha M Adhikari; U P Rathnakar
Journal:  Perspect Clin Res       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.